Moriyoshi Yasuda

Errata: Effectiveness and Adverse Events of Tolvaptan in Octogenarians With Heart Failure.

N. Sato, K. Kinugawa, T. Inomata, 2015, International heart journal.

Effectiveness and adverse events of tolvaptan in octogenarians with heart failure. Interim analyses of Samsca Post-Marketing Surveillance In Heart faiLurE (SMILE study).

N. Sato, K. Kinugawa, T. Inomata, 2015, International heart journal.

A Prospective, Multicenter, Post-Marketing Surveillance Study to Evaluate the Safety and Effectiveness of Tolvaptan in Patients with Reduced, Preserved, and Mid-Range Ejection Fraction Heart Failure.

N. Sato, K. Kinugawa, T. Inomata, 2019, International heart journal.

Real-World Effectiveness and Tolerability of Tolvaptan in Patients With Heart Failure　- Final Results of the Samsca Post-Marketing Surveillance in Heart Failure (SMILE) Study.

N. Sato, K. Kinugawa, T. Inomata, 2019, Circulation journal : official journal of the Japanese Circulation Society.

Real-World Effectiveness and Tolerability of Tolvaptan in Patients With Heart Failure

N. Sato, K. Kinugawa, T. Inomata, 2019 .

Novel Risk Score Efficiently Prevents Tolvaptan-Induced Hypernatremic Events in Patients With Heart Failure.

Y. Shibasaki, N. Sato, K. Kinugawa, 2018, Circulation journal : official journal of the Japanese Circulation Society.

Real-world effectiveness and safety of aripiprazole augmentation therapy in patients with major depressive disorder

K. Kamijima, Moriyoshi Yasuda, Y. Fukuta, 2018, Current medical research and opinion.

Effectiveness and safety of tolvaptan in liver cirrhosis patients with edema: Interim results of post‐marketing surveillance of tolvaptan in liver cirrhosis (START study)

M. Kurosaki, S. Terai, I. Sakaida, 2016, Hepatology research : the official journal of the Japan Society of Hepatology.

Who Needs Longer Tolvaptan Treatment?

N. Sato, K. Kinugawa, T. Inomata, 2017, International heart journal.

Who Needs Longer Tolvaptan Treatment? An Interim Analysis From the Samsca post-Marketing surveillance In heart faiLurE (SMILE study)

N. Sato, K. Kinugawa, T. Inomata, 2017 .